Mega Lifesciences PCL (BKK:MEGA)

Market Cap	24.85B
Revenue (ttm)	14.86B
Net Income (ttm)	1.98B
Shares Out	871.87M
EPS (ttm)	2.28
PE Ratio	12.51
Forward PE	11.45
Dividend	1.60 (5.33%)
Ex-Dividend Date	Mar 7, 2025

Volume	1,182,885
Average Volume	1,204,252
Open	29.50
Previous Close	30.00
Day's Range	28.50 - 29.75
52-Week Range	26.50 - 41.00
Beta	0.26
RSI	44.41
Earnings Date	May 14, 2025

About Mega Lifesciences PCL

Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa. The company operates in three segments: Brands, Distribution, and Original Equipment Manufacture (OEM). It provides various medicines for allergies; blood circulation and memory; bone and joint; liver and digestive; diabetics; eyes, heart, and skin care; pain, sl...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1982
• Employees: 900
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: MEGA

Financial Performance

In 2024, Mega Lifesciences PCL's revenue was 15.39 billion, a decrease of -2.10% compared to the previous year's 15.72 billion. Earnings were 2.01 billion, an increase of 0.99%.